規制動向

FDA、EMA、TGA および世界の規制動向

#Rabeprazole ×

2026年8月30日•1分で読めます

FDA Approves ANDA076885 for Rabeprazole Sodium

FDA has approved ANDA076885 for Rabeprazole Sodium oral delayed‑release tablets (20 mg) sponsored by Pharmobedient, with multiple labeling submissions approved between 2013 and 2023.